FI88112C
(sv)
*
|
1985-07-30 |
1993-04-13 |
Glaxo Group Ltd |
Anordning för administrering av läkemedel till patienter
|
IT1222509B
(it)
*
|
1987-08-17 |
1990-09-05 |
Miat Spa |
Insufflatore per la somministrazione di farmaci sotto forma di polvere predosata in opercoli
|
US4817789A
(en)
*
|
1987-09-23 |
1989-04-04 |
Allergan, Inc. |
Lens container assembly
|
FR2626500B1
(fr)
*
|
1988-01-28 |
1990-04-27 |
Valois Sa |
Poussoir de vaporisateur agence pour operer le melange d'un additif dans l'emission du jet
|
CH678151A5
(en)
*
|
1988-07-13 |
1991-08-15 |
Heinz Hermann Weick |
Self-medication nasal dispenser
|
GB8824804D0
(en)
*
|
1988-10-22 |
1988-11-30 |
Fisons Plc |
Device
|
SE466684B
(sv)
*
|
1989-03-07 |
1992-03-23 |
Draco Ab |
Anordning vid en inhalator samt foerfarande foer att med anordningen registrera medicinering med inhalator
|
US5176132A
(en)
*
|
1989-05-31 |
1993-01-05 |
Fisons Plc |
Medicament inhalation device and formulation
|
US5239991A
(en)
*
|
1989-06-21 |
1993-08-31 |
Fisons Plc |
Disposable powder medicament inhalation device with peel-off cover
|
IT1230313B
(it)
*
|
1989-07-07 |
1991-10-18 |
Somova Spa |
Inalatore per medicamenti in capsule.
|
DE3927170A1
(de)
*
|
1989-08-17 |
1991-02-21 |
Boehringer Ingelheim Kg |
Inhalator
|
US5270305A
(en)
*
|
1989-09-08 |
1993-12-14 |
Glaxo Group Limited |
Medicaments
|
US5208226A
(en)
*
|
1989-09-08 |
1993-05-04 |
Glaxo Group Limited |
Medicaments
|
DK544589D0
(da)
*
|
1989-11-01 |
1989-11-01 |
Novo Nordisk As |
Manuel betjent apparat til dispensering af en forudbestemt maengde af et pulverformet stof
|
SK280967B6
(sk)
*
|
1990-03-02 |
2000-10-09 |
Glaxo Group Limited |
Inhalačný prístroj
|
US6536427B2
(en)
|
1990-03-02 |
2003-03-25 |
Glaxo Group Limited |
Inhalation device
|
GB9004781D0
(en)
*
|
1990-03-02 |
1990-04-25 |
Glaxo Group Ltd |
Device
|
YU48707B
(sh)
|
1990-03-02 |
1999-07-28 |
Glaxo Group Limited |
Aparat za inhaliranje - inhalator
|
GB9012870D0
(en)
*
|
1990-06-08 |
1990-08-01 |
Glaxo Group Ltd |
Device
|
GB9015522D0
(en)
*
|
1990-07-13 |
1990-08-29 |
Braithwaite Philip W |
Inhaler
|
IT1243344B
(it)
*
|
1990-07-16 |
1994-06-10 |
Promo Pack Sa |
Inalatore plurimonodose per medicamenti in polvere
|
SE9002895D0
(sv)
*
|
1990-09-12 |
1990-09-12 |
Astra Ab |
Inhalation devices for dispensing powders i
|
US5429122A
(en)
*
|
1990-09-26 |
1995-07-04 |
Zanen; Pieter |
Inhaler devices provided with a reservoir for several doses of medium for inhaling, transporting device, whirl chamber
|
FR2667509B1
(fr)
*
|
1990-10-04 |
1995-08-25 |
Valois |
Inhalateur a poudre, dispositif de conditionnement de microdoses de poudre sous forme de bandes adaptees a etre utilisees dans un inhalateur a poudre, et procede de fabrication de ces bandes.
|
NL9002706A
(nl)
*
|
1990-12-10 |
1992-07-01 |
Pharmachemie Bv |
Inrichting ten gebruike bij het inhaleren van in staafvormige capsules verpakte poedervormige stoffen.
|
US5243970A
(en)
*
|
1991-04-15 |
1993-09-14 |
Schering Corporation |
Dosing device for administering metered amounts of powdered medicaments to patients
|
US5492112A
(en)
*
|
1991-05-20 |
1996-02-20 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler
|
US6681767B1
(en)
|
1991-07-02 |
2004-01-27 |
Nektar Therapeutics |
Method and device for delivering aerosolized medicaments
|
ES2141108T3
(es)
*
|
1991-07-02 |
2000-03-16 |
Inhale Inc |
Metodo y dispositivo para proporcionar medicamentos en aerosol.
|
US5337740A
(en)
*
|
1991-08-01 |
1994-08-16 |
New England Pharmaceuticals, Inc. |
Inhalation devices
|
US5161524A
(en)
*
|
1991-08-02 |
1992-11-10 |
Glaxo Inc. |
Dosage inhalator with air flow velocity regulating means
|
US5287850A
(en)
*
|
1991-08-20 |
1994-02-22 |
Habley Medical Technology Corporation |
Timing and velocity controlled powered pharmaceutical inhaler
|
DE4128295A1
(de)
*
|
1991-08-27 |
1993-03-04 |
Pfeiffer Erich Gmbh & Co Kg |
Austragvorrichtung fuer fliessfaehige medien
|
GB9124468D0
(en)
*
|
1991-11-18 |
1992-01-08 |
Smithkline Beecham Plc |
Novel device
|
DE4211475A1
(de)
*
|
1991-12-14 |
1993-06-17 |
Asta Medica Ag |
Pulverinhalator
|
GB2264237A
(en)
*
|
1992-02-05 |
1993-08-25 |
Robert Edward Newell |
An inhaler
|
GB9203761D0
(en)
*
|
1992-02-21 |
1992-04-08 |
Innovata Biomed Ltd |
Inhaler
|
EP0558879B1
(en)
*
|
1992-03-04 |
1997-05-14 |
Astra Aktiebolag |
Disposable inhaler
|
US5301664A
(en)
*
|
1992-03-06 |
1994-04-12 |
Sievers Robert E |
Methods and apparatus for drug delivery using supercritical solutions
|
JPH0633935Y2
(ja)
*
|
1992-03-27 |
1994-09-07 |
サカセ化学工業株式会社 |
グルーピングメディシンプール
|
DE59307510D1
(de)
*
|
1992-05-29 |
1997-11-13 |
Ggu Gesundheits Umweltforsch |
Vorrichtung zur erzeugung inhalierbarer wirkstoffpartikel
|
US5394868A
(en)
*
|
1992-06-25 |
1995-03-07 |
Schering Corporation |
Inhalation device for powdered medicaments
|
US6673335B1
(en)
*
|
1992-07-08 |
2004-01-06 |
Nektar Therapeutics |
Compositions and methods for the pulmonary delivery of aerosolized medicaments
|
US6509006B1
(en)
|
1992-07-08 |
2003-01-21 |
Inhale Therapeutic Systems, Inc. |
Devices compositions and methods for the pulmonary delivery of aerosolized medicaments
|
US5785049A
(en)
|
1994-09-21 |
1998-07-28 |
Inhale Therapeutic Systems |
Method and apparatus for dispersion of dry powder medicaments
|
US6582728B1
(en)
|
1992-07-08 |
2003-06-24 |
Inhale Therapeutic Systems, Inc. |
Spray drying of macromolecules to produce inhaleable dry powders
|
US7448375B2
(en)
*
|
1993-01-29 |
2008-11-11 |
Aradigm Corporation |
Method of treating diabetes mellitus in a patient
|
US6024090A
(en)
*
|
1993-01-29 |
2000-02-15 |
Aradigm Corporation |
Method of treating a diabetic patient by aerosolized administration of insulin lispro
|
KR960701672A
(ko)
*
|
1993-03-03 |
1996-03-28 |
윌리엄 피. 알트만 |
건조 분말 흡입기의 약제 캐리어(dry powder inhalator medicament carrier)
|
TW360548B
(en)
|
1993-04-08 |
1999-06-11 |
Powderject Res Ltd |
Products for therapeutic use
|
US5372128A
(en)
*
|
1993-04-14 |
1994-12-13 |
Habley Medical Technology Corporation |
Fluidizing powder inhaler
|
US5533502A
(en)
*
|
1993-05-28 |
1996-07-09 |
Vortran Medical Technology, Inc. |
Powder inhaler with aerosolization occurring within each individual powder receptacle
|
BE1007408A3
(nl)
*
|
1993-08-13 |
1995-06-06 |
Winters Joep |
Werkwijze en inrichting voor het controleren van het gebruik van een geneesmiddel.
|
US5524613A
(en)
*
|
1993-08-25 |
1996-06-11 |
Habley Medical Technology Corporation |
Controlled multi-pharmaceutical inhaler
|
US5388572A
(en)
*
|
1993-10-26 |
1995-02-14 |
Tenax Corporation (A Connecticut Corp.) |
Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same
|
US5388573A
(en)
*
|
1993-12-02 |
1995-02-14 |
Tenax Corporation |
Dry powder inhalator medicament carrier
|
PT101450B
(pt)
*
|
1994-02-02 |
1999-11-30 |
Hovione Produtos Farmaceuticos |
Novo dispositivo para inalacao
|
ES2218543T3
(es)
*
|
1994-03-07 |
2004-11-16 |
Nektar Therapeutics |
Procedimiento y preparacion para la administracion de insulina por via pulmonar.
|
US6051256A
(en)
*
|
1994-03-07 |
2000-04-18 |
Inhale Therapeutic Systems |
Dispersible macromolecule compositions and methods for their preparation and use
|
US6102036A
(en)
*
|
1994-04-12 |
2000-08-15 |
Smoke-Stop |
Breath activated inhaler
|
AU696387B2
(en)
*
|
1994-05-18 |
1998-09-10 |
Inhale Therapeutic Systems, Inc. |
Methods and compositions for the dry powder formulation of interferons
|
US5483954A
(en)
*
|
1994-06-10 |
1996-01-16 |
Mecikalski; Mark B. |
Inhaler and medicated package
|
US6290991B1
(en)
*
|
1994-12-02 |
2001-09-18 |
Quandrant Holdings Cambridge Limited |
Solid dose delivery vehicle and methods of making same
|
AU697676B2
(en)
*
|
1994-09-21 |
1998-10-15 |
Nektar Therapeutics |
Apparatus and methods for dispersing dry powder medicaments
|
FR2725626A1
(fr)
*
|
1994-10-18 |
1996-04-19 |
Sofab |
Dispositif pour l'inhalation de produits en poudre
|
DE19500764C2
(de)
*
|
1995-01-13 |
2001-09-27 |
Sofotec Gmbh & Co Kg |
Vorrichtung zum Verabreichen von Medikamenten in fester, in einem Luftstrom fein verteilter Form
|
US5676643A
(en)
*
|
1995-02-13 |
1997-10-14 |
The Procter & Gamble Company |
Dispenser for friably releasing dry particulate medicaments
|
US5780014A
(en)
*
|
1995-04-14 |
1998-07-14 |
Inhale Therapeutic Systems |
Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin
|
US5622166A
(en)
*
|
1995-04-24 |
1997-04-22 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler delivery system
|
US5921237A
(en)
*
|
1995-04-24 |
1999-07-13 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler
|
US5669973A
(en)
*
|
1995-06-06 |
1997-09-23 |
David Sarnoff Research Center, Inc. |
Apparatus for electrostatically depositing and retaining materials upon a substrate
|
US5714007A
(en)
*
|
1995-06-06 |
1998-02-03 |
David Sarnoff Research Center, Inc. |
Apparatus for electrostatically depositing a medicament powder upon predefined regions of a substrate
|
US20040237961A1
(en)
*
|
1995-06-08 |
2004-12-02 |
Snow John Medlin |
Inhalation actuated device for use with metered dose inhalers (MDIs)
|
US6672304B1
(en)
|
1995-06-08 |
2004-01-06 |
Innovative Devices, Llc |
Inhalation actuated device for use with metered dose inhalers (MDIs)
|
DE19523516C1
(de)
*
|
1995-06-30 |
1996-10-31 |
Asta Medica Ag |
Inhalator zum Verabreichen von Medikamenten aus Blisterpackungen
|
US5642727A
(en)
*
|
1995-07-25 |
1997-07-01 |
David Sarnoff Research Center, Inc. |
Inhaler apparatus using a tribo-electric charging technique
|
US5823183A
(en)
*
|
1995-08-02 |
1998-10-20 |
Innovative Devices |
Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament
|
US5988163A
(en)
*
|
1995-08-02 |
1999-11-23 |
Innovative Devices |
Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of delivery of medicament
|
US5692496A
(en)
*
|
1995-08-02 |
1997-12-02 |
Innovative Devices, Llc |
Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament
|
US6209538B1
(en)
|
1995-08-02 |
2001-04-03 |
Robert A. Casper |
Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament
|
NL1001031C1
(nl)
*
|
1995-08-23 |
1997-02-25 |
Npk Ind Design B V |
Inrichting voor het afgeven van pillen uit een blisterverpakking.
|
US5649554A
(en)
*
|
1995-10-16 |
1997-07-22 |
Philip Morris Incorporated |
Electrical lighter with a rotatable tobacco supply
|
US5827985A
(en)
*
|
1995-12-19 |
1998-10-27 |
Endress + Hauser Gmbh + Co. |
Sensor apparatus for process measurement
|
US5669378A
(en)
*
|
1995-12-21 |
1997-09-23 |
Pera; Ivo |
Inhaling device
|
CN1213974A
(zh)
|
1996-01-03 |
1999-04-14 |
葛兰素集团有限公司 |
吸入器具
|
USD381416S
(en)
*
|
1996-02-08 |
1997-07-22 |
Astra Aktiebolag |
Unit dose inhaler
|
US5743251A
(en)
|
1996-05-15 |
1998-04-28 |
Philip Morris Incorporated |
Aerosol and a method and apparatus for generating an aerosol
|
GB9610821D0
(en)
*
|
1996-05-23 |
1996-07-31 |
Glaxo Wellcome Inc |
Metering apparatus
|
US5871010A
(en)
*
|
1996-06-10 |
1999-02-16 |
Sarnoff Corporation |
Inhaler apparatus with modified surfaces for enhanced release of dry powders
|
US5857456A
(en)
*
|
1996-06-10 |
1999-01-12 |
Sarnoff Corporation |
Inhaler apparatus with an electronic means for enhanced release of dry powders
|
GB9616047D0
(en)
|
1996-07-31 |
1996-09-11 |
Glaxo Group Ltd |
Medicament carrier with agglomerated large medicament particles and related method of manufacture thereof
|
AU5719798A
(en)
|
1996-12-31 |
1998-07-31 |
Inhale Therapeutic Systems, Inc. |
Processes for spray drying aqueous suspensions of hydrophobic drugs with hydrophilic excipients and compositions prepared by such processes
|
US20030203036A1
(en)
*
|
2000-03-17 |
2003-10-30 |
Gordon Marc S. |
Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients
|
US5794613A
(en)
*
|
1997-01-09 |
1998-08-18 |
Sepracor, Inc. |
Multiple-dose dispenser for dry powder inhalers
|
TW469832U
(en)
*
|
1997-03-14 |
2001-12-21 |
Astra Ab |
Inhalation device
|
US6006747A
(en)
*
|
1997-03-20 |
1999-12-28 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler
|
US20030035778A1
(en)
*
|
1997-07-14 |
2003-02-20 |
Robert Platz |
Methods and compositions for the dry powder formulation of interferon
|
US6237590B1
(en)
*
|
1997-09-18 |
2001-05-29 |
Delsys Pharmaceutical Corporation |
Dry powder delivery system apparatus
|
USD417731S
(en)
*
|
1997-10-22 |
1999-12-14 |
The Procter & Gamble Company |
Container for nasal spray
|
DE69840876D1
(de)
*
|
1997-12-02 |
2009-07-16 |
Valois Sas |
Trockenpulverinhalator
|
US6116238A
(en)
*
|
1997-12-02 |
2000-09-12 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler
|
US6237591B1
(en)
|
1998-11-02 |
2001-05-29 |
Dura Pharmaceuticals, Inc. |
Turbine dry powder inhaler
|
SI20413A
(sl)
|
1998-03-16 |
2001-06-30 |
Inhale Therapeutic Systems, Inc. |
Dajanje aerosoliziranega aktivnega sredstva
|
DE19817417A1
(de)
*
|
1998-04-18 |
1999-10-21 |
Pfeiffer Erich Gmbh & Co Kg |
Spender für Medien, insbesondere Pulver
|
US6257233B1
(en)
|
1998-06-04 |
2001-07-10 |
Inhale Therapeutic Systems |
Dry powder dispersing apparatus and methods for their use
|
US6149774A
(en)
*
|
1998-06-10 |
2000-11-21 |
Delsys Pharmaceutical Corporation |
AC waveforms biasing for bead manipulating chucks
|
DE19831525A1
(de)
*
|
1998-07-14 |
2000-01-20 |
Pfeiffer Erich Gmbh & Co Kg |
Spender für Medien
|
KR100522910B1
(ko)
*
|
1998-09-15 |
2005-12-21 |
주식회사 새 한 |
청량감이 우수한 폴리에스테르 가연가공사의 제조방법
|
UA73924C2
(en)
*
|
1998-10-09 |
2005-10-17 |
Nektar Therapeutics |
Device for delivering active agent formulation to lungs of human patient
|
US6234167B1
(en)
|
1998-10-14 |
2001-05-22 |
Chrysalis Technologies, Incorporated |
Aerosol generator and methods of making and using an aerosol generator
|
US6923979B2
(en)
*
|
1999-04-27 |
2005-08-02 |
Microdose Technologies, Inc. |
Method for depositing particles onto a substrate using an alternating electric field
|
ATE294608T1
(de)
|
1999-06-05 |
2005-05-15 |
Innovata Biomed Ltd |
Verabreichungsystem für medikamente
|
US9006175B2
(en)
|
1999-06-29 |
2015-04-14 |
Mannkind Corporation |
Potentiation of glucose elimination
|
US6606992B1
(en)
|
1999-06-30 |
2003-08-19 |
Nektar Therapeutics |
Systems and methods for aerosolizing pharmaceutical formulations
|
US7305986B1
(en)
|
1999-07-23 |
2007-12-11 |
Mannkind Corporation |
Unit dose capsules for use in a dry powder inhaler
|
US6730066B1
(en)
*
|
1999-08-03 |
2004-05-04 |
Pharmacia Ab |
Liquid delivery container
|
GB9920839D0
(en)
|
1999-09-04 |
1999-11-10 |
Innovata Biomed Ltd |
Inhaler
|
GB9924415D0
(en)
*
|
1999-10-16 |
1999-12-15 |
Glaxo Group Ltd |
Medicament pack
|
AU1752601A
(en)
*
|
1999-11-11 |
2001-06-06 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler
|
US6810872B1
(en)
|
1999-12-10 |
2004-11-02 |
Unisia Jecs Corporation |
Inhalant medicator
|
US6679256B2
(en)
|
1999-12-17 |
2004-01-20 |
Nektar Therapeutics |
Systems and methods for extracting powders from receptacles
|
MY136453A
(en)
*
|
2000-04-27 |
2008-10-31 |
Philip Morris Usa Inc |
"improved method and apparatus for generating an aerosol"
|
US6883516B2
(en)
|
2000-04-27 |
2005-04-26 |
Chrysalis Technologies Incorporated |
Method for generating an aerosol with a predetermined and/or substantially monodispersed particle size distribution
|
US6948494B1
(en)
*
|
2000-05-10 |
2005-09-27 |
Innovative Devices, Llc. |
Medicament container with same side airflow inlet and outlet and method of use
|
GB0015034D0
(en)
*
|
2000-06-21 |
2000-08-09 |
Glaxo Group Ltd |
Inhalation device
|
AR028746A1
(es)
*
|
2000-06-23 |
2003-05-21 |
Norton Health Care Ltd |
Cartucho de dosis previamente medidas para inhalador de polvo seco accionado por la respiracion, el inhalador y un metodo de provision de dosis previamente medidas de polvo seco
|
US7575761B2
(en)
*
|
2000-06-30 |
2009-08-18 |
Novartis Pharma Ag |
Spray drying process control of drying kinetics
|
EP1172122A1
(en)
*
|
2000-07-14 |
2002-01-16 |
The Technology Partnership Public Limited Company |
Dry powder inhaler
|
US6759398B2
(en)
|
2000-08-05 |
2004-07-06 |
Smithkline Beecham Corporation |
Anti-inflammatory androstane derivative
|
EP1305329B2
(en)
|
2000-08-05 |
2015-03-18 |
Glaxo Group Limited |
6.alpha.,9.alpha.-difluoro-17.alpha.-(2-furanylcarboxyl)oxy-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent
|
EP1315533A4
(en)
*
|
2000-08-15 |
2007-06-27 |
Univ Kentucky Res Found |
PROGRAMMABLE MULTI-DOSE DEVICE FOR INTRANASAL MEDICINE ADMINISTRATION
|
SE517229C2
(sv)
*
|
2000-09-25 |
2002-05-14 |
Microdrug Ag |
Kontinuerlig inhalator för torrt pulver
|
GB0023654D0
(en)
|
2000-09-27 |
2000-11-08 |
Cambridge Consultants |
Device for administering doses of particulate material
|
US6595210B2
(en)
|
2000-11-27 |
2003-07-22 |
Unisia Jecs Corporation |
Inhalator for administering powder composition
|
US6491233B2
(en)
|
2000-12-22 |
2002-12-10 |
Chrysalis Technologies Incorporated |
Vapor driven aerosol generator and method of use thereof
|
US6681998B2
(en)
|
2000-12-22 |
2004-01-27 |
Chrysalis Technologies Incorporated |
Aerosol generator having inductive heater and method of use thereof
|
US6501052B2
(en)
|
2000-12-22 |
2002-12-31 |
Chrysalis Technologies Incorporated |
Aerosol generator having multiple heating zones and methods of use thereof
|
US6799572B2
(en)
*
|
2000-12-22 |
2004-10-05 |
Chrysalis Technologies Incorporated |
Disposable aerosol generator system and methods for administering the aerosol
|
US6701921B2
(en)
*
|
2000-12-22 |
2004-03-09 |
Chrysalis Technologies Incorporated |
Aerosol generator having heater in multilayered composite and method of use thereof
|
US7077130B2
(en)
*
|
2000-12-22 |
2006-07-18 |
Chrysalis Technologies Incorporated |
Disposable inhaler system
|
ES2291452T3
(es)
*
|
2001-02-06 |
2008-03-01 |
Innovata Biomed Limited |
Formulacion bimodal de polvo seco para inhalacion.
|
GB0103630D0
(en)
|
2001-02-14 |
2001-03-28 |
Glaxo Group Ltd |
Chemical compounds
|
ATE381537T1
(de)
|
2001-03-22 |
2008-01-15 |
Glaxo Group Ltd |
Formanilid-derivative als beta2-adrenorezeptor- agonisten
|
WO2002092154A1
(en)
|
2001-04-26 |
2002-11-21 |
New England Pharmaceuticals, Inc. |
Metered dose delivery device for liquid and powder agents
|
BR0209271A
(pt)
|
2001-04-30 |
2004-06-15 |
Glaxo Group Ltd |
Composto, uso de um composto composição farmacêutica, formulação em aerossol farmacêutica, método para o tratamento de um paciente humano ou animal com uma condição inflamatória e/ou alérgica, e, processo para a preparação de um composto
|
US6681768B2
(en)
|
2001-06-22 |
2004-01-27 |
Sofotec Gmbh & Co. Kg |
Powder formulation disintegrating system and method for dry powder inhalers
|
US8061006B2
(en)
*
|
2001-07-26 |
2011-11-22 |
Powderject Research Limited |
Particle cassette, method and kit therefor
|
US7176278B2
(en)
|
2001-08-30 |
2007-02-13 |
Biorexis Technology, Inc. |
Modified transferrin fusion proteins
|
US6540081B2
(en)
*
|
2001-09-06 |
2003-04-01 |
Ecolab Inc. |
Unit dose blister pack product dispenser
|
SI1425001T1
(sl)
|
2001-09-14 |
2009-04-30 |
Glaxo Group Ltd Glaxo Welcome |
Fenetanolaminski derivati za zdravljenje respiratornih bolezni
|
WO2003024396A2
(en)
|
2001-09-17 |
2003-03-27 |
Glaxo Group Limited |
Dry powder medicament formulations
|
JP4261351B2
(ja)
|
2001-09-19 |
2009-04-30 |
アドヴェント ファーマセウティカルズ プロプライエタリー リミテッド |
吸入器
|
US6640050B2
(en)
|
2001-09-21 |
2003-10-28 |
Chrysalis Technologies Incorporated |
Fluid vaporizing device having controlled temperature profile heater/capillary tube
|
US6568390B2
(en)
|
2001-09-21 |
2003-05-27 |
Chrysalis Technologies Incorporated |
Dual capillary fluid vaporizing device
|
US7931022B2
(en)
*
|
2001-10-19 |
2011-04-26 |
Respirks, Inc. |
Method and apparatus for dispensing inhalator medicament
|
US20030094173A1
(en)
*
|
2001-11-14 |
2003-05-22 |
Inhale Therapeutic Systems, Inc. |
Aerosolization device with improved endpiece connection
|
GB0128148D0
(en)
|
2001-11-23 |
2002-01-16 |
Innovata Biomed Ltd |
Assembly
|
US6681769B2
(en)
|
2001-12-06 |
2004-01-27 |
Crysalis Technologies Incorporated |
Aerosol generator having a multiple path heater arrangement and method of use thereof
|
US6804458B2
(en)
|
2001-12-06 |
2004-10-12 |
Chrysalis Technologies Incorporated |
Aerosol generator having heater arranged to vaporize fluid in fluid passage between bonded layers of laminate
|
US20030168057A1
(en)
*
|
2001-12-14 |
2003-09-11 |
Inhale Therapeutic Systems, Inc. |
Electronically controllable aerosol delivery
|
US6701922B2
(en)
|
2001-12-20 |
2004-03-09 |
Chrysalis Technologies Incorporated |
Mouthpiece entrainment airflow control for aerosol generators
|
US7458373B2
(en)
|
2002-01-15 |
2008-12-02 |
Philip Morris Usa Inc. |
Aerosol generator for drug formulation
|
GB0201677D0
(en)
*
|
2002-01-25 |
2002-03-13 |
Glaxo Group Ltd |
Medicament dispenser
|
GB0217199D0
(en)
*
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicament dispenser
|
US20070062525A1
(en)
*
|
2002-01-25 |
2007-03-22 |
Bonney Stanley G |
Medicament dispenser
|
WO2003074164A1
(en)
*
|
2002-03-01 |
2003-09-12 |
Glaxo Group Limited |
Rotary blending apparatus and system
|
AU2003220222A1
(en)
|
2002-03-13 |
2003-09-29 |
Signum Biosciences, Inc. |
Modulation of protein methylation and phosphoprotein phosphate
|
DE10212264A1
(de)
|
2002-03-20 |
2003-10-02 |
Boehringer Ingelheim Pharma |
Kristallines Mikronisat, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung eines Arzneimittels
|
ES2425392T3
(es)
|
2002-03-20 |
2013-10-15 |
Mannkind Corporation |
Cartucho para un aparato de inhalación
|
JP2006504446A
(ja)
*
|
2002-03-26 |
2006-02-09 |
グラクソ グループ リミテッド |
ラミネート・アセンブリーの形成方法、およびそれにより形成される製品
|
GR1004350B
(el)
*
|
2002-03-29 |
2003-09-26 |
|
Συσκευη εισπνοων ξηρης σκονης
|
US20030235538A1
(en)
|
2002-04-09 |
2003-12-25 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Method for the administration of an anticholinergic by inhalation
|
DE10216429A1
(de)
|
2002-04-12 |
2003-10-23 |
Boehringer Ingelheim Pharma |
Arzneimittel enthaltend Steroide und ein neues Anticholinergikum
|
GB0208608D0
(en)
*
|
2002-04-13 |
2002-05-22 |
Glaxo Group Ltd |
Composition
|
GB0208609D0
(en)
*
|
2002-04-13 |
2002-05-22 |
Glaxo Group Ltd |
Compositions
|
GB0216562D0
(en)
*
|
2002-04-25 |
2002-08-28 |
Bradford Particle Design Ltd |
Particulate materials
|
AU2003228683A1
(en)
*
|
2002-04-25 |
2003-11-10 |
Glaxo Group Limited |
Magnetoacoustic sensor system and associated method for sensing environmental conditions
|
EP1497261B1
(en)
|
2002-04-25 |
2007-12-19 |
Glaxo Group Limited |
Phenethanolamine derivatives
|
US9339459B2
(en)
|
2003-04-24 |
2016-05-17 |
Nektar Therapeutics |
Particulate materials
|
WO2003095005A1
(en)
*
|
2002-05-10 |
2003-11-20 |
Chrysalis Technologies Incorporated |
Aerosol generator for drug formulation and methods of generating aerosol
|
US7089786B2
(en)
*
|
2002-05-15 |
2006-08-15 |
Glaxo Group Limited |
Microelectromechanical system and method for determining temperature and moisture profiles within pharmaceutical packaging
|
US7185651B2
(en)
*
|
2002-06-18 |
2007-03-06 |
Nektar Therapeutics |
Flow regulator for aerosol drug delivery and methods
|
WO2004004725A2
(en)
|
2002-07-09 |
2004-01-15 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases
|
DE10230751A1
(de)
|
2002-07-09 |
2004-01-22 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Arzneimittelkompositionen auf der Basis neuer Anticholinergika und EGFR-Kinase-Hemmern
|
GB0217196D0
(en)
*
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicament dispenser
|
WO2004011068A1
(en)
*
|
2002-07-25 |
2004-02-05 |
Glaxo Group Limited |
Medicament dispenser
|
GB0217225D0
(en)
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicinal compounds
|
EP1534367A1
(en)
*
|
2002-07-25 |
2005-06-01 |
Glaxo Group Limited |
Medicament dispenser
|
GB0217198D0
(en)
*
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicament dispenser
|
DE60335401D1
(de)
|
2002-09-06 |
2011-01-27 |
Philip Morris Usa Inc |
Aerosolerzeugungsvorrichtungen und verfahren zur erzeugung von aerosolen mit gesteuerten teilchengrössen
|
WO2004024308A1
(en)
*
|
2002-09-13 |
2004-03-25 |
Glaxo Group Limited |
Coated blending system
|
US6962266B2
(en)
*
|
2002-10-04 |
2005-11-08 |
Ecolab Inc. |
Method and apparatus for using a unit dose dispenser
|
AU2003298094A1
(en)
*
|
2002-10-22 |
2004-05-13 |
Glaxo Group Limited |
Medicinal arylethanolamine compounds
|
US6772757B2
(en)
|
2002-10-25 |
2004-08-10 |
Chrysalis Technologies Incorporated |
Concentric controlled temperature profile fluid vaporizing device
|
ATE390407T1
(de)
|
2002-10-28 |
2008-04-15 |
Glaxo Group Ltd |
Phenethanolamin-derivate zur behandlung von atemwegserkrankungen
|
US7056916B2
(en)
|
2002-11-15 |
2006-06-06 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Medicaments for the treatment of chronic obstructive pulmonary disease
|
US6941947B2
(en)
*
|
2002-12-18 |
2005-09-13 |
Quadrant Technologies Limited |
Unit dose dry powder inhaler
|
AU2003293361A1
(en)
*
|
2002-12-18 |
2004-07-29 |
Glaxo Group Limited |
Drug delivery system with vented mouthpiece
|
US20060241130A1
(en)
*
|
2003-01-31 |
2006-10-26 |
Ehud Keinan |
Anti-inflammatory compositions and uses thereof
|
EP1594528A1
(en)
*
|
2003-02-11 |
2005-11-16 |
Boehringer Ingelheim International GmbH |
New pharmaceutical compositions based on anticholinergics and soluble tnf receptor fusion proteins
|
US20060251656A1
(en)
*
|
2003-02-11 |
2006-11-09 |
Boehringer Ingelheim International Gmbh |
New pharmaceutical compositions based on anticholinergics and anti-tnf antibodies
|
GB0303396D0
(en)
|
2003-02-14 |
2003-03-19 |
Glaxo Group Ltd |
Medicinal compounds
|
PE20040950A1
(es)
|
2003-02-14 |
2005-01-01 |
Theravance Inc |
DERIVADOS DE BIFENILO COMO AGONISTAS DE LOS RECEPTORES ADRENERGICOS ß2 Y COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS
|
DE10317461A1
(de)
|
2003-04-16 |
2004-10-28 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Radioaktiv markierte Mikropartikel, Verfahren zu deren Herstellung und deren Verwendung
|
US20040245279A1
(en)
*
|
2003-05-05 |
2004-12-09 |
Bradley Tareasa L. |
System for dispensing an active ingredient using a dispensable tablet, dispensable tablet and container for holding such dispensable tablets
|
TW200510298A
(en)
|
2003-06-13 |
2005-03-16 |
Theravance Inc |
Substituted pyrrolidine and related compounds
|
EP1488819A1
(en)
*
|
2003-06-16 |
2004-12-22 |
Rijksuniversiteit te Groningen |
Dry powder inhaler and method for pulmonary inhalation of dry powder
|
GB0315509D0
(en)
|
2003-07-02 |
2003-08-06 |
Meridica Ltd |
Dispensing device
|
GB0316335D0
(en)
*
|
2003-07-11 |
2003-08-13 |
Glaxo Group Ltd |
Pharmaceutical formulations
|
AR045914A1
(es)
|
2003-07-17 |
2005-11-16 |
Glaxo Group Ltd |
Compuesto alcoholico terciario del 8-azoniabiciclo [3.2.1] octano, composicion farmaceutica que lo comprende y su uso para preparar esta ultima
|
GB0317374D0
(en)
|
2003-07-24 |
2003-08-27 |
Glaxo Group Ltd |
Medicament dispenser
|
NZ545442A
(en)
|
2003-07-29 |
2010-05-28 |
Boehringer Ingelheim Int |
Medicaments for inhalation comprising betamimetics and an aclidinium salt known as 3-(2-hydroxy-2,2-dithiophen-2-yl-acetoxy)-1-(3-phenoxypropyl)-l-azoniabicyclo[2.2.2]octane
|
US7367334B2
(en)
|
2003-08-27 |
2008-05-06 |
Philip Morris Usa Inc. |
Fluid vaporizing device having controlled temperature profile heater/capillary tube
|
US6991131B2
(en)
*
|
2003-09-02 |
2006-01-31 |
Ecolab, Inc. |
Distributable container and system and method using distributable container
|
WO2005028006A1
(en)
*
|
2003-09-24 |
2005-03-31 |
Medi-Stream Pty Ltd |
Medication holder
|
AU2004273547B2
(en)
*
|
2003-09-24 |
2006-07-06 |
Tianda Pharmaceuticals (Australia) Pty Ltd |
Medication holder
|
NZ556424A
(en)
|
2003-10-14 |
2008-12-24 |
Glaxo Group Ltd |
Muscarinic Acetylcholine receptor antagonists
|
EA200600787A1
(ru)
|
2003-10-17 |
2006-08-25 |
Глэксо Груп Лимитед |
Антагонисты мускариновых ацетилхолиновых рецепторов
|
GB2407042B
(en)
|
2003-10-17 |
2007-10-24 |
Vectura Ltd |
Inhaler
|
GB0324654D0
(en)
*
|
2003-10-22 |
2003-11-26 |
Glaxo Group Ltd |
Medicinal compounds
|
GB0324897D0
(en)
*
|
2003-10-24 |
2003-11-26 |
Glaxo Group Ltd |
Composition
|
GB0324886D0
(en)
*
|
2003-10-24 |
2003-11-26 |
Glaxo Group Ltd |
Medicinal compounds
|
WO2005041848A2
(en)
*
|
2003-10-27 |
2005-05-12 |
Oriel Therapeutics, Inc. |
Dry powder drug containment system packages with tabs, inhalers and associated methods
|
JP2007509941A
(ja)
*
|
2003-10-28 |
2007-04-19 |
グラクソ グループ リミテッド |
ラクトース無水物を用いる吸入医薬製剤およびその投与方法
|
GB0325627D0
(en)
*
|
2003-11-03 |
2003-12-10 |
Glaxo Group Ltd |
A hand-held capsule device
|
PT1682541E
(pt)
|
2003-11-03 |
2010-04-14 |
Boehringer Ingelheim Int |
Processo para a preparação de sais de tiotrópio
|
PL2083007T3
(pl)
|
2003-11-03 |
2013-09-30 |
Boehringer Ingelheim Int |
Sole tiotropium, sposoby ich wytwarzania oraz zawierające je kompozycje farmaceutyczne
|
PE20050489A1
(es)
|
2003-11-04 |
2005-09-02 |
Glaxo Group Ltd |
Antagonistas de receptores de acetilcolina muscarinicos
|
GB0329182D0
(en)
|
2003-12-17 |
2004-01-21 |
Glaxo Group Ltd |
Chemical compounds
|
US8147426B2
(en)
*
|
2003-12-31 |
2012-04-03 |
Nipro Diagnostics, Inc. |
Integrated diagnostic test system
|
GB2410947B
(en)
*
|
2004-02-11 |
2008-09-17 |
Cambridge Lab Ltd |
Pharmaceutical compounds
|
TWI341836B
(en)
|
2004-03-11 |
2011-05-11 |
Theravance Inc |
Biphenyl compounds useful as muscarinic receptor antagonists
|
JP2007529513A
(ja)
|
2004-03-17 |
2007-10-25 |
グラクソ グループ リミテッド |
M3ムスカリン性アセチルコリン受容体アンタゴニスト
|
KR20070000508A
(ko)
*
|
2004-04-02 |
2007-01-02 |
글락소 그룹 리미티드 |
화학적 방법 및 결정형
|
EP1744800B1
(en)
*
|
2004-04-21 |
2016-06-22 |
Innovata Biomed Limited |
Inhaler
|
SG152237A1
(en)
|
2004-04-22 |
2009-05-29 |
Boehringer Ingelheim Int |
Pharmaceutical combinations containing benzoxazine for treating respiratory diseases
|
US20050272726A1
(en)
*
|
2004-04-22 |
2005-12-08 |
Boehringer Ingelheim International Gmbh |
Novel medicaments for the treatment of respiratory diseases
|
US7861712B2
(en)
*
|
2004-04-23 |
2011-01-04 |
Manta Product Development |
Sealed capsule including an integrated puncturing mechanism
|
GB0409197D0
(en)
|
2004-04-24 |
2004-05-26 |
Innovata Biomed Ltd |
Device
|
UY28871A1
(es)
|
2004-04-27 |
2005-11-30 |
Glaxo Group Ltd |
Antagonistas del receptor de acetilcolina muscarinico
|
US7727962B2
(en)
*
|
2004-05-10 |
2010-06-01 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Powder comprising new compositions of oligosaccharides and methods for their preparation
|
US7611709B2
(en)
*
|
2004-05-10 |
2009-11-03 |
Boehringer Ingelheim Pharma Gmbh And Co. Kg |
1,4 O-linked saccharose derivatives for stabilization of antibodies or antibody derivatives
|
US7723306B2
(en)
*
|
2004-05-10 |
2010-05-25 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Spray-dried powder comprising at least one 1,4 O-linked saccharose-derivative and methods for their preparation
|
EP1747219A4
(en)
|
2004-05-13 |
2010-05-26 |
Glaxo Group Ltd |
Antagonists of muscarinic acetylcholine receptor
|
US20050256115A1
(en)
*
|
2004-05-14 |
2005-11-17 |
Boehringer Ingelheim International Gmbh |
Aerosol formulation for the inhalation of beta-agonists
|
US7220742B2
(en)
|
2004-05-14 |
2007-05-22 |
Boehringer Ingelheim International Gmbh |
Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
|
WO2005110519A1
(en)
*
|
2004-05-17 |
2005-11-24 |
Sun Pharmaceutical Industries Limited |
Dry powder inhaler
|
SE530006C2
(sv)
*
|
2004-06-18 |
2008-02-05 |
Mederio Ag |
Inhalator som använder balja
|
US7896195B2
(en)
*
|
2004-06-08 |
2011-03-01 |
Ecolab Inc. |
Tablet dispenser with isolated product hopper
|
US20050283106A1
(en)
*
|
2004-06-17 |
2005-12-22 |
Shane Smith |
Reusable support device with therapeutic inserts
|
US20060035893A1
(en)
|
2004-08-07 |
2006-02-16 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
|
US20060079544A1
(en)
*
|
2004-08-13 |
2006-04-13 |
Boehringer Ingelheim International Gmbh |
Medicaments for the prevention or treatment of alveolar pneumonia comprising an anticholinergic
|
GB0418278D0
(en)
*
|
2004-08-16 |
2004-09-15 |
Glaxo Group Ltd |
Medicament dispenser
|
ATE486064T1
(de)
|
2004-08-20 |
2010-11-15 |
Mannkind Corp |
Katalyse der diketopiperazinsynthese
|
GB0418738D0
(en)
*
|
2004-08-23 |
2004-09-22 |
3M Innovative Properties Co |
Medicinal aerosol formulation receptacle and production thereof
|
PL1791542T3
(pl)
|
2004-08-23 |
2015-11-30 |
Mannkind Corp |
Sole diketopiperazyny do dostarczania leków
|
WO2006047663A2
(en)
*
|
2004-10-26 |
2006-05-04 |
The University Of North Carolina At Chapel Hill |
Aerosol generation of therapeutic agents
|
JP2006130143A
(ja)
*
|
2004-11-08 |
2006-05-25 |
Hitachi Ltd |
吸入式投薬器及び薬剤カートリッジ
|
US20060120972A1
(en)
*
|
2004-11-09 |
2006-06-08 |
Peter Engels |
9-(N-methyl-piperidyliden-4)-thioxanthene for treatment of pulmonary hypertension
|
US20080042823A1
(en)
*
|
2004-11-12 |
2008-02-21 |
Heasley Matthew G |
Sensor System with Acoustic Transducer
|
EP2486942B1
(en)
|
2004-11-24 |
2018-10-10 |
Meda Pharmaceuticals Inc. |
Compositions comprising azelastine and methods of use thereof
|
US20070020330A1
(en)
|
2004-11-24 |
2007-01-25 |
Medpointe Healthcare Inc. |
Compositions comprising azelastine and methods of use thereof
|
US8758816B2
(en)
*
|
2004-11-24 |
2014-06-24 |
Meda Pharmaceuticals Inc. |
Compositions comprising azelastine and methods of use thereof
|
GB0427853D0
(en)
*
|
2004-12-20 |
2005-01-19 |
Glaxo Group Ltd |
Manifold for use in medicament dispenser
|
GB0427858D0
(en)
*
|
2004-12-20 |
2005-01-19 |
Glaxo Group Ltd |
Manifold for use in medicament dispenser
|
GB0427856D0
(en)
*
|
2004-12-20 |
2005-01-19 |
Glaxo Group Ltd |
Maniflod for use in medicament dispenser
|
MX2007008459A
(es)
*
|
2005-01-11 |
2007-07-25 |
Glaxo Group Ltd |
Sales de cinamato de un agonista beta-2 adrenergico.
|
US7923041B2
(en)
|
2005-02-03 |
2011-04-12 |
Signum Biosciences, Inc. |
Compositions and methods for enhancing cognitive function
|
WO2006084033A1
(en)
*
|
2005-02-03 |
2006-08-10 |
Signum Biosciences, Inc. |
Compositions and methods for enhancing cognitive function
|
EP1858528A2
(en)
*
|
2005-02-10 |
2007-11-28 |
Glaxo Group Limited |
Process for crystallizing lactose particles for use in pharmaceutical formulations
|
ES2613391T3
(es)
|
2005-02-10 |
2017-05-24 |
Glaxo Group Limited |
Procedimientos de fabricación de lactosa que utilizan técnicas de preclasificación y formulaciones farmacéuticas formadas a partir de la misma
|
PE20100737A1
(es)
|
2005-03-25 |
2010-11-27 |
Glaxo Group Ltd |
Nuevos compuestos
|
PE20100741A1
(es)
|
2005-03-25 |
2010-11-25 |
Glaxo Group Ltd |
COMPUESTOS DERIVADOS DE 3,4-DIHIDROPIRIMIDO[4,5-d]PIRIMIDIN-2(1H)-ONA COMO INHIBIDORES DE QUINASA p38
|
GB0507711D0
(en)
|
2005-04-15 |
2005-05-25 |
Vectura Group Plc |
Improved blister piercing
|
US9585932B2
(en)
|
2005-04-29 |
2017-03-07 |
Peter C. Dowling |
Use of EPO-derived peptide fragments for the treatment of neurodegenerative disorders
|
WO2007052154A2
(en)
|
2005-04-29 |
2007-05-10 |
University Of Medicine And Dentistry Of New Jersey |
Erythropoietin-derived short peptide and its mimics as immuno/inflammatory modulators
|
US9345745B2
(en)
|
2005-04-29 |
2016-05-24 |
Bo Wang |
Methods for treating inflammatory disorders and traumatic brain injury using stabilized non-hematopoietic EPO short peptides
|
EP1881980B1
(en)
|
2005-05-02 |
2012-08-22 |
Boehringer Ingelheim International GmbH |
Novel crystalline forms of tiotropium bromide
|
US8524734B2
(en)
|
2005-05-18 |
2013-09-03 |
Mpex Pharmaceuticals, Inc. |
Aerosolized fluoroquinolones and uses thereof
|
DK1901749T3
(en)
|
2005-05-18 |
2016-10-24 |
Raptor Pharmaceuticals Inc |
Aerosolized fluoroquinolones AND USES THEREOF
|
CA2611907A1
(en)
*
|
2005-06-17 |
2006-12-21 |
Boehringer Ingelheim International Gmbh |
Mrp iv inhibitors for the treatment of respiratory diseases
|
DE102005030733A1
(de)
*
|
2005-07-01 |
2007-01-04 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen enthaltend langwirksame Beta-2-Agonisten und wenigstens einen weiteren Wirkstoff
|
GB0514501D0
(en)
*
|
2005-07-14 |
2005-08-24 |
Cambridge Lab Ireland Ltd |
Pharmaceutical compounds
|
US20070012316A1
(en)
*
|
2005-07-14 |
2007-01-18 |
Joann Truza |
Disposable compact rescue inhaler
|
US8763605B2
(en)
|
2005-07-20 |
2014-07-01 |
Manta Devices, Llc |
Inhalation device
|
GB0515584D0
(en)
*
|
2005-07-28 |
2005-09-07 |
Glaxo Group Ltd |
Medicament dispenser
|
GB0516168D0
(en)
*
|
2005-08-05 |
2005-09-14 |
Cambridge Lab Ireland Ltd |
Pharmaceutical compounds
|
JP5270343B2
(ja)
*
|
2005-08-15 |
2013-08-21 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
ベータミメティックスの製造方法
|
EP1937068A4
(en)
|
2005-08-18 |
2010-08-04 |
Glaxo Group Ltd |
ANTAGONISTS OF ACETYLCHOLINE MUSCARINIC RECEPTORS
|
US20090192227A1
(en)
*
|
2005-08-24 |
2009-07-30 |
Rabindra Tirouvanziam |
N-Acetylcysteine Compositions and Methods for Treating Acute Exacerbations of Inflammatory Lung Disease
|
US20070049641A1
(en)
*
|
2005-08-24 |
2007-03-01 |
Rabindra Tirouvanziam |
Methods for treating and monitoring inflammation and redox imbalance cystic fibrosis
|
US8227408B2
(en)
*
|
2005-09-07 |
2012-07-24 |
Neurotez, Inc. |
Leptin as an anti-amyloidogenic biologic and methods for delaying the onset and reducing Alzheimer's disease-like pathology
|
US20130131007A1
(en)
|
2005-09-07 |
2013-05-23 |
Bebaas, Inc. |
Vitamin b12 compositions
|
US20070178141A1
(en)
*
|
2005-09-07 |
2007-08-02 |
Bebaas, Inc. |
Vitamin B12 compositions
|
US8716220B2
(en)
*
|
2005-09-07 |
2014-05-06 |
Nikolaos Tezapsidis |
Leptin compositions and methods for treating progressive cognitive function disorders resulting from accumulation of neurofibrillary tangles and amyloid beta
|
US7481331B2
(en)
*
|
2005-09-09 |
2009-01-27 |
Manrex Limited |
Dispensing container for a blister pack of medications
|
AU2006290870B2
(en)
|
2005-09-14 |
2013-02-28 |
Mannkind Corporation |
Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces
|
TWI396541B
(zh)
|
2005-10-10 |
2013-05-21 |
Boehringer Ingelheim Int |
用於治療呼吸疾病之新穎藥物組合
|
US9107824B2
(en)
|
2005-11-08 |
2015-08-18 |
Insmed Incorporated |
Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
|
DE102005057685A1
(de)
*
|
2005-12-01 |
2007-06-06 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Inhalator und Speicher für eine trockene Arzneimittelformulierung sowie diesbezügliche Verfahren und Verwendung
|
AR058290A1
(es)
*
|
2005-12-12 |
2008-01-30 |
Glaxo Group Ltd |
Dispensador de medicamento
|
AR058289A1
(es)
*
|
2005-12-12 |
2008-01-30 |
Glaxo Group Ltd |
Colector para ser usado en dispensador de medicamento
|
DE102005059602A1
(de)
|
2005-12-14 |
2007-06-21 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Verfahren zur Mikronisierung
|
EP2497484A3
(en)
|
2006-02-22 |
2012-11-07 |
MannKind Corporation |
A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
|
US8127763B2
(en)
*
|
2006-03-03 |
2012-03-06 |
Stc.Unm |
Dry powder inhaler with aeroelastic dispersion mechanism
|
CN101437562A
(zh)
*
|
2006-03-03 |
2009-05-20 |
Stc.Unm公司 |
具有气动力弹性分散机构的干粉吸入器
|
DE102006016904A1
(de)
*
|
2006-04-11 |
2007-10-25 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Inhalator
|
EP1844805A1
(de)
*
|
2006-04-13 |
2007-10-17 |
Boehringer Ingelheim Pharma GmbH & Co.KG |
Inhalator
|
EP1844808A1
(de)
*
|
2006-04-13 |
2007-10-17 |
BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG |
Medikamenten-Ausgabevorrichtung
|
PT103481B
(pt)
|
2006-05-16 |
2008-08-01 |
Hovione Farmaciencia S A |
Inalador de uso simples e método de inalação
|
US8133588B2
(en)
|
2006-05-19 |
2012-03-13 |
Valspar Sourcing, Inc. |
Coating system for cement composite articles
|
US20090250058A1
(en)
*
|
2006-07-14 |
2009-10-08 |
Astrazeneca Ab |
Inhalation System and Delivery Device for the Administration of a Drug in the Form of Dry Powder
|
US20090324510A1
(en)
|
2006-08-07 |
2009-12-31 |
Boehringer Ingelheim International Gmbh |
Drug combinations for the treatment of respiratory tract diseases
|
PE20081358A1
(es)
*
|
2006-08-22 |
2008-10-31 |
Boehringer Ingelheim Int |
Combinaciones farmacologicas para el tratamiento de enfermedades de la vias aereas
|
DE102006045788A1
(de)
|
2006-09-26 |
2008-03-27 |
Alfred Von Schuckmann |
Spender für pulverförmige Massen
|
NZ576637A
(en)
|
2006-10-25 |
2012-05-25 |
Novartis Ag |
Powder dispersion apparatus with and mediciment receptacles that are cut open using an elliptical arc shaped knife blade oriented to yaw between 4 and 12 degrees
|
GB0622827D0
(en)
*
|
2006-11-15 |
2006-12-27 |
Glaxo Group Ltd |
Sheet driver for use in a drug dispenser
|
EP1925295A1
(de)
|
2006-11-22 |
2008-05-28 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Stabile Pulverformulierung enthaltend ein Anticholinergikum
|
EP2155228B1
(en)
*
|
2007-01-10 |
2014-04-02 |
Purdue Research Foundation |
Polypeptide inhibitors of hsp27 kinase and uses therefor
|
AR065804A1
(es)
|
2007-03-23 |
2009-07-01 |
Smithkline Beecham Corp |
Compuesto de indol carboxamida, composicion farmaceutica que lo comprende y uso de dicho compuesto para preparar un medicamento
|
US20080237082A1
(en)
*
|
2007-03-29 |
2008-10-02 |
R. P. Scherer Technologies, Inc. |
Child resistant device for housing blister packs
|
AT505246B8
(de)
*
|
2007-06-01 |
2009-06-15 |
Croma Pharma Gmbh |
Container für eine mehrzahl von einzeldosen sowie applikator für derartige container
|
US11224704B2
(en)
|
2007-07-06 |
2022-01-18 |
Manta Devices, Llc |
Dose delivery device for inhalation
|
EP3453418A1
(en)
|
2007-07-06 |
2019-03-13 |
Manta Devices, LLC |
Delivery device and related methods
|
ES2547229T3
(es)
|
2007-08-07 |
2015-10-02 |
Purdue Research Foundation |
Inhibidores de cinasa y usos de los mismos
|
EP2093219A1
(de)
|
2008-02-22 |
2009-08-26 |
Boehringer Ingelheim International Gmbh |
Kristalline, enantiomerenreine Salzform eines Betamimetikums und dessen Verwendung als Arzneimittel
|
WO2009117151A2
(en)
*
|
2008-03-20 |
2009-09-24 |
Virun, Inc. |
Compositions containing non-polar compounds
|
WO2009117152A1
(en)
*
|
2008-03-20 |
2009-09-24 |
Virun, Inc. |
Emulsions including a peg-derivative of tocopherol
|
EP2326339A4
(en)
*
|
2008-05-21 |
2012-06-20 |
Neurotez Inc |
METHOD FOR TREATING PROGRESSIVE COGNITIVE DISORDER IN CONNECTION WITH NEUROFIBRILLARY TANGLES
|
GB0810857D0
(en)
*
|
2008-06-13 |
2008-07-23 |
Cambridge Lab Ireland Ltd |
Pharmaceutical compounds
|
US8485180B2
(en)
|
2008-06-13 |
2013-07-16 |
Mannkind Corporation |
Dry powder drug delivery system
|
DK2570147T3
(da)
|
2008-06-13 |
2018-01-29 |
Mannkind Corp |
Tørpulverinhalator og system til lægemiddelindgivelse
|
KR101628410B1
(ko)
|
2008-06-20 |
2016-06-08 |
맨카인드 코포레이션 |
흡입 활동에 관한 실시간 프로파일링을 위한 대화형 장치 및 방법
|
US8337931B2
(en)
*
|
2008-06-23 |
2012-12-25 |
Virun, Inc. |
Compositions containing non-polar compounds
|
JP5339794B2
(ja)
*
|
2008-07-04 |
2013-11-13 |
キヤノン株式会社 |
吸入装置
|
TWI532497B
(zh)
|
2008-08-11 |
2016-05-11 |
曼凱公司 |
超快起作用胰島素之用途
|
US20110053866A1
(en)
*
|
2008-08-12 |
2011-03-03 |
Biovail Laboratories International (Barbados) S.R.L. |
Pharmaceutical compositions
|
GB2462611A
(en)
*
|
2008-08-12 |
2010-02-17 |
Cambridge Lab |
Pharmaceutical composition comprising tetrabenazine
|
GB2463451A
(en)
|
2008-09-08 |
2010-03-17 |
Cambridge Lab |
3, 11b cis-dihydrotetrabenazine compounds for use in the treatment of dementia
|
GB2463452A
(en)
*
|
2008-09-08 |
2010-03-17 |
Cambridge Lab |
Desmethyl derivatives of tetrabenazine and pharmaceutical compositions thereof
|
GB2463283A
(en)
*
|
2008-09-08 |
2010-03-10 |
Cambridge Lab |
3,11b-cis-dihydrotetrabenazine for use in treating asthma
|
MX2011003244A
(es)
|
2008-09-26 |
2011-04-28 |
Oriel Therapeutics Inc |
Inhaladores con discos de vias aereas con canales de vias aereas discretas y discos y metodos relacionados.
|
MX2011003233A
(es)
|
2008-09-26 |
2011-04-28 |
Oriel Therapeutics Inc |
Inhaladores de polvo seco con miembros de perforacion doble y dispositivos y metodos relacionados.
|
EP2346554B1
(en)
*
|
2008-09-26 |
2015-09-16 |
Oriel Therapeutics, Inc. |
Inhaler mechanisms with radially biased piercers and related methods
|
WO2010039201A2
(en)
*
|
2008-09-30 |
2010-04-08 |
Oriel Therapeutics, Inc. |
Dry powder inhalers with multi-facet surface deagglomeration chambers and related devices and methods
|
CA2732827C
(en)
*
|
2008-10-01 |
2016-10-11 |
Oriel Therapeutics, Inc. |
Dry powder inhalers with rotating piercing mechanisms and related devices and methods
|
KR20110091510A
(ko)
|
2008-10-07 |
2011-08-11 |
엠펙스 파마슈티컬즈, 인코포레이티드 |
약동학 개선을 위한 에어로졸 플루오로퀴놀론 제형
|
CA2739893C
(en)
|
2008-10-07 |
2016-10-04 |
Mpex Pharmaceuticals, Inc. |
Inhalation of levofloxacin for reducing lung inflammation
|
CA2741302C
(en)
*
|
2008-10-20 |
2017-02-28 |
Moerae Matrix, Inc. |
Mapkap kinase inhibitor polypeptide for treating or preventing adhesions
|
EP2378875B1
(en)
*
|
2008-12-10 |
2018-05-30 |
Purdue Research Foundation |
Cell-permeant peptide-based inhibitor of kinases
|
US8314106B2
(en)
|
2008-12-29 |
2012-11-20 |
Mannkind Corporation |
Substituted diketopiperazine analogs for use as drug delivery agents
|
US8550074B2
(en)
|
2009-01-15 |
2013-10-08 |
Manta Devices, Llc |
Delivery device and related methods
|
GB0901520D0
(en)
*
|
2009-01-30 |
2009-03-11 |
Vectura Delivery Devices Ltd |
Inhaler
|
WO2010091198A1
(en)
|
2009-02-06 |
2010-08-12 |
University Of Southern California |
Therapeutic compositions comprising monoterpenes
|
US20120129820A1
(en)
|
2009-02-09 |
2012-05-24 |
Boehringer Ingelheim International Gmbh |
New pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
|
EP2400950B1
(en)
|
2009-02-26 |
2019-05-22 |
Glaxo Group Limited |
Pharmaceutical formulations comprising 4-{(1 r)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol
|
CA2754595C
(en)
|
2009-03-11 |
2017-06-27 |
Mannkind Corporation |
Apparatus, system and method for measuring resistance of an inhaler
|
MX357919B
(es)
*
|
2009-03-13 |
2018-07-25 |
Nucitec Sa De Cv |
Composición farmacéutica para el tratamiento de la hipercolesterolemia.
|
CA2992927A1
(en)
|
2009-03-18 |
2010-09-23 |
Mannkind Corporation |
Inhaler adaptor for a laser diffraction apparatus and method for measuring particle size distribution
|
US8734845B2
(en)
|
2009-06-12 |
2014-05-27 |
Mannkind Corporation |
Diketopiperazine microparticles with defined specific surface areas
|
EP2443134A2
(en)
|
2009-06-16 |
2012-04-25 |
Schering Corporation |
NOVEL [3,2-c]HETEROARYL STEROIDS AS GLUCOCORTICOID RECEPTOR AGONISTS, COMPOSITIONS AND USES THEREOF
|
EP2451787B1
(en)
|
2009-07-06 |
2013-04-24 |
Boehringer Ingelheim International GmbH |
Polymorph of [4,6-bis(dimethylamino)-2-(4-{[4-(trifluoromethyl)benzoyl]amino}benzyl)pyrimidin-5-yl]
|
PT2453894E
(pt)
|
2009-07-15 |
2016-02-02 |
Theravance Biopharma R&D Ip Llc |
Forma de base livre cristalina de um composto bifenilo
|
US8933217B2
(en)
|
2009-07-24 |
2015-01-13 |
Amazentis Sa |
Compounds, compositions, and methods for protecting brain health in neurodegenerative disorders
|
US9890195B2
(en)
*
|
2009-07-27 |
2018-02-13 |
Purdue Research Foundation |
MK2 inhibitor compositions and methods to enhance neurite outgrowth, neuroprotection, and nerve regeneration
|
RU2015130524A
(ru)
|
2009-09-04 |
2018-12-21 |
Раптор Фармасьютикалз Инк. |
Применение левофлоксацина в форме аэрозоля для лечения муковисцидоза
|
WO2011035128A1
(en)
*
|
2009-09-17 |
2011-03-24 |
Mutual Pharmaceutical Company, Inc. |
Method of treating asthma with antiviral agents
|
CA2778698A1
(en)
|
2009-11-03 |
2011-05-12 |
Mannkind Corporation |
An apparatus and method for simulating inhalation efforts
|
WO2011060334A2
(en)
|
2009-11-12 |
2011-05-19 |
Stc.Unm |
Dry powder inhaler with flutter dispersion member
|
EP2504319A1
(en)
|
2009-11-24 |
2012-10-03 |
Boehringer Ingelheim International GmbH |
Process for preparing a polymorph of the choline salt of a pyrimidin-5-yl acetic acid derivative
|
US20120302584A1
(en)
|
2009-11-24 |
2012-11-29 |
Boehringer Ingelheim International Gmbh |
Novel salts forms of pyrimidin-5-yl acetic acid derivative
|
GB0921075D0
(en)
|
2009-12-01 |
2010-01-13 |
Glaxo Group Ltd |
Novel combination of the therapeutic agents
|
US10210216B2
(en)
*
|
2009-12-18 |
2019-02-19 |
Sybase, Inc. |
Dynamic attributes for mobile business objects
|
EP2542082B8
(en)
|
2010-03-03 |
2020-06-17 |
Neonc Technologies Inc. |
PHARMACEUTICAL COMPOSITIONS COMPRISING (S)-perillyl alcohol
|
WO2011116293A2
(en)
|
2010-03-19 |
2011-09-22 |
Manta Devices, Llc |
Delivery device and related methods
|
WO2011119228A1
(en)
|
2010-03-23 |
2011-09-29 |
Virun, Inc. |
Nanoemulsion including sucrose fatty acid ester
|
USD635246S1
(en)
|
2010-03-26 |
2011-03-29 |
Oriel Therapeutics, Inc. |
Dose disk for dry powder inhalers
|
USD641076S1
(en)
|
2010-03-26 |
2011-07-05 |
Oriel Therapeutics, Inc. |
Dry powder inhaler
|
US8741373B2
(en)
|
2010-06-21 |
2014-06-03 |
Virun, Inc. |
Compositions containing non-polar compounds
|
RU2531455C2
(ru)
|
2010-06-21 |
2014-10-20 |
Маннкайнд Корпорейшн |
Системы и способы доставки сухих порошковых лекарств
|
EP3685835A1
(en)
|
2010-08-27 |
2020-07-29 |
Neonc Technologies, Inc. |
Pharmaceutical compositions comprising poh derivatives
|
US20160038600A1
(en)
|
2012-08-03 |
2016-02-11 |
Neonc Technologies Inc. |
Pharmaceutical compositions comprising poh derivatives
|
AU2011298315B2
(en)
|
2010-08-31 |
2014-08-28 |
Glaxo Group Limited |
Dry powder inhalation drug products exhibiting moisture control properties and methods of administering the same
|
EP3461474B1
(en)
|
2010-08-31 |
2020-11-11 |
GlaxoSmithKline Intellectual Property Development Limited |
Dry powder inhalation drug products exhibiting moisture control properties and methods of administering the same
|
WO2012064286A1
(en)
|
2010-11-11 |
2012-05-18 |
Agency For Science, Technology And Research |
Targeting metabolic enzymes in human cancer
|
US8561609B2
(en)
|
2010-12-07 |
2013-10-22 |
Respira Therapeutics, Inc. |
Dry powder inhaler
|
EP3130579B1
(en)
|
2010-12-17 |
2024-02-07 |
University of Southern California |
Conjugates of isoperillyl alcohol
|
US10092552B2
(en)
|
2011-01-31 |
2018-10-09 |
Avalyn Pharma Inc. |
Aerosol pirfenidone and pyridone analog compounds and uses thereof
|
MY180552A
(en)
|
2011-04-01 |
2020-12-02 |
Mannkind Corp |
Blister package for pharmaceutical cartridges
|
US9890200B2
(en)
|
2011-04-12 |
2018-02-13 |
Moerae Matrix, Inc. |
Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
|
AU2012242768B2
(en)
|
2011-04-12 |
2017-10-12 |
Moerae Matrix, Inc. |
Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
|
EP2709646A4
(en)
|
2011-05-19 |
2015-05-13 |
Savara Inc |
DRY POWDER VANCOMYCIN COMPOSITIONS AND RELATED METHODS
|
WO2012174472A1
(en)
|
2011-06-17 |
2012-12-20 |
Mannkind Corporation |
High capacity diketopiperazine microparticles
|
US8528569B1
(en)
|
2011-06-28 |
2013-09-10 |
Kyle D. Newton |
Electronic cigarette with liquid reservoir
|
US11103659B2
(en)
|
2011-07-06 |
2021-08-31 |
Manta Devices, Llc |
Delivery device and related methods
|
GB201116641D0
(en)
|
2011-09-27 |
2011-11-09 |
Glaxo Group Ltd |
Novel compounds
|
WO2013063160A1
(en)
|
2011-10-24 |
2013-05-02 |
Mannkind Corporation |
Methods and compositions for treating pain
|
EP2589381B1
(en)
|
2011-11-04 |
2016-08-31 |
Rabindra Tirouvanziam |
Compositions for improving or preserving lung function in a patient with a pulmonary disorder
|
US9603907B2
(en)
|
2012-02-01 |
2017-03-28 |
Protalix Ltd. |
Dry powder formulations of dNase I
|
EP2811847B1
(en)
|
2012-02-10 |
2017-12-13 |
Virun, Inc. |
Beverage compositions containing non-polar compounds
|
US10463815B2
(en)
|
2012-02-21 |
2019-11-05 |
Respira Therapeutics, Inc. |
Inhaler to deliver substances for prophylaxis or prevention of disease or injury caused by the inhalation of biological or chemical agents
|
WO2013134636A1
(en)
|
2012-03-09 |
2013-09-12 |
Purdue Research Foundation |
Compositions and methods for delivery of kinase inhibiting peptides
|
GB201207406D0
(en)
|
2012-04-27 |
2012-06-13 |
Glaxo Group Ltd |
Novel compounds
|
UY34765A
(es)
|
2012-04-27 |
2013-11-29 |
Glaxo Group Ltd |
Compuestos novedosos.
|
US9649454B2
(en)
|
2012-05-03 |
2017-05-16 |
Manta Devices, Llc |
Delivery device and related methods
|
WO2013176638A1
(en)
|
2012-05-25 |
2013-11-28 |
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi |
An inhaler comprising a mouthpiece having an improved air channel
|
CA2878457C
(en)
|
2012-07-12 |
2021-01-19 |
Mannkind Corporation |
Dry powder drug delivery systems and methods
|
CN105025904A
(zh)
|
2012-09-04 |
2015-11-04 |
埃莱森制药有限责任公司 |
用顺铂脂质复合物预防癌症的肺部复发
|
WO2014066856A1
(en)
|
2012-10-26 |
2014-05-01 |
Mannkind Corporation |
Inhalable influenza vaccine compositions and methods
|
AU2013352288B2
(en)
|
2012-11-28 |
2017-11-23 |
Intercept Pharmaceuticals, Inc. |
Treatment of pulmonary disease
|
GB201301192D0
(en)
|
2013-01-23 |
2013-03-06 |
Vectura Delivery Devices Ltd |
A blister piercing element for a dry powder inhaler
|
BR112015023168B1
(pt)
|
2013-03-15 |
2021-08-10 |
Mannkind Corporation |
Composição de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina cristalina, método de produção de partículas de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina e uso de uma composição de dicetopiperazina cristalina
|
US9351517B2
(en)
|
2013-03-15 |
2016-05-31 |
Virun, Inc. |
Formulations of water-soluble derivatives of vitamin E and compositions containing same
|
DK177788B1
(en)
|
2013-07-12 |
2014-07-07 |
Liita Holdings Ltd |
Inhaler
|
CN114848614A
(zh)
|
2013-07-18 |
2022-08-05 |
曼金德公司 |
热稳定性干粉药物组合物和方法
|
WO2015017728A1
(en)
|
2013-07-31 |
2015-02-05 |
Windward Pharma, Inc. |
Aerosol tyrosine kinase inhibitor compounds and uses thereof
|
CA2920488C
(en)
|
2013-08-05 |
2022-04-26 |
Mannkind Corporation |
Insufflation apparatus and methods
|
US9693574B2
(en)
|
2013-08-08 |
2017-07-04 |
Virun, Inc. |
Compositions containing water-soluble derivatives of vitamin E mixtures and modified food starch
|
CN105873913B
(zh)
|
2013-09-10 |
2019-12-03 |
得克萨斯***大学评议会 |
靶向截短的腺瘤性结肠息肉(apc)蛋白的治疗法
|
US10980273B2
(en)
|
2013-11-12 |
2021-04-20 |
VMR Products, LLC |
Vaporizer, charger and methods of use
|
US10076139B2
(en)
|
2013-12-23 |
2018-09-18 |
Juul Labs, Inc. |
Vaporizer apparatus
|
FI3491948T4
(sv)
|
2013-12-23 |
2024-05-06 |
Juul Labs International Inc |
Förångningsanordningssystem
|
US10058129B2
(en)
|
2013-12-23 |
2018-08-28 |
Juul Labs, Inc. |
Vaporization device systems and methods
|
USD769438S1
(en)
*
|
2014-01-08 |
2016-10-18 |
Glaxo Group Limited |
Inhaler device
|
NZ722927A
(en)
|
2014-01-10 |
2022-07-29 |
Avalyn Pharma Inc |
Aerosol pirfenidone and pyridone analog compounds and uses thereof
|
US10709173B2
(en)
|
2014-02-06 |
2020-07-14 |
Juul Labs, Inc. |
Vaporizer apparatus
|
TWI684414B
(zh)
|
2014-02-06 |
2020-02-11 |
美商尤爾實驗室有限公司 |
汽化裝置系統及方法
|
US10307464B2
(en)
|
2014-03-28 |
2019-06-04 |
Mannkind Corporation |
Use of ultrarapid acting insulin
|
US10336788B2
(en)
|
2014-04-17 |
2019-07-02 |
Moerae Matrix, Inc. |
Inhibition of cardiac fibrosis in myocardial infarction
|
CN106456445B
(zh)
|
2014-04-24 |
2019-11-15 |
奎斯塔公司 |
多尺寸药丸分割器以及方法
|
WO2015168572A2
(en)
*
|
2014-05-02 |
2015-11-05 |
Manta Devices, Llc |
Delivery device and related methods
|
WO2015173701A2
(en)
|
2014-05-12 |
2015-11-19 |
Glaxosmithkline Intellectual Property (No. 2) Limited |
Pharmaceutical compositions for treating infectious diseases
|
US10940279B2
(en)
*
|
2014-07-01 |
2021-03-09 |
Jennifer K. Keener |
Aromatherapy device
|
US10082496B2
(en)
|
2014-09-10 |
2018-09-25 |
Board Of Regents Of The University Of Texas System |
Targeting emopamil binding protein (EBP) with small molecules that induce an abnormal feedback response by lowering endogenous cholesterol biosynthesis
|
US9861611B2
(en)
|
2014-09-18 |
2018-01-09 |
Virun, Inc. |
Formulations of water-soluble derivatives of vitamin E and soft gel compositions, concentrates and powders containing same
|
US10016363B2
(en)
|
2014-09-18 |
2018-07-10 |
Virun, Inc. |
Pre-spray emulsions and powders containing non-polar compounds
|
US10561806B2
(en)
|
2014-10-02 |
2020-02-18 |
Mannkind Corporation |
Mouthpiece cover for an inhaler
|
US20170304459A1
(en)
|
2014-10-10 |
2017-10-26 |
Alnylam Pharmaceuticals, Inc. |
Methods and compositions for inhalation delivery of conjugated oligonucleotide
|
AU2015338717B2
(en)
|
2014-10-31 |
2018-12-20 |
Glaxosmithkline Intellectual Property Development Limited |
Powder formulation
|
US10500249B2
(en)
|
2014-11-17 |
2019-12-10 |
Moerae Matrix Inc. |
Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
|
EP3229831B1
(en)
|
2014-12-10 |
2020-03-11 |
Hyperstem SA |
Methods and compositions for reducing growth, migration and invasiveness of brain cancer stem cells and improving survival of patients with brain tumors
|
US10087225B2
(en)
|
2015-01-08 |
2018-10-02 |
Moerae Matrix, Inc. |
Formulation of MK2 inhibitor peptides
|
JP2018501903A
(ja)
|
2015-01-14 |
2018-01-25 |
レスピラ セラピューティクス インコーポレイテッドRespira Therapeutics,Inc. |
パウダー分散方法および装置
|
US9522918B2
(en)
|
2015-02-12 |
2016-12-20 |
Neonc Technologies, Inc. |
Pharmaceutical compositions comprising perillyl alcohol derivatives
|
EP3061501A1
(en)
|
2015-02-27 |
2016-08-31 |
Rottapharm Ltd. |
Composition for the treatment of acne
|
BR112017019412A2
(pt)
|
2015-03-11 |
2018-05-02 |
Glaxosmithkline Ip Dev Ltd |
proteínas ligadoras de tslp
|
BR112017019343A2
(pt)
|
2015-03-12 |
2018-05-02 |
Moerae Matrix Inc |
uso de composições contendo peptídeo inibidor de mk2 para tratamento de câncer de pulmão de células não pequenas com as mesmas
|
US10179215B2
(en)
|
2015-03-19 |
2019-01-15 |
Altria Client Services Llc |
Vaporizer for vaporizing a constituent of a plant material
|
AU2016201131B2
(en)
*
|
2015-03-30 |
2020-04-02 |
Manrex Limited |
Dispensing container for blister pack of medication
|
WO2016200694A1
(en)
|
2015-06-10 |
2016-12-15 |
Hackensack University Medical Center |
Use of telmisartan to prevent and treat graft versus host disease and other alloimmune and autoimmune diseases
|
RU2018101077A
(ru)
|
2015-06-15 |
2019-07-15 |
Глэксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед |
Регуляторы nrf2
|
CA2988374A1
(en)
|
2015-06-15 |
2016-12-22 |
Glaxosmithkline Intellectual Property Development Limited |
Nrf2 regulators
|
PT3307739T
(pt)
|
2015-06-15 |
2021-01-04 |
Glaxosmithkline Ip Dev Ltd |
Reguladores de nrf2
|
WO2017007634A1
(en)
|
2015-07-06 |
2017-01-12 |
The Board Of Regents Of The University Of Texas System |
Benzamide or benzamine compounds useful as anticancer agents for the treatment of human cancers
|
WO2017011215A1
(en)
|
2015-07-15 |
2017-01-19 |
The Board Of Regents Of The University Of Texas System |
Targeting emopamil binding protein (ebp) with small molecules that induce an abnormal feedback response by lowering endogenous cholesterol biosynthesis
|
EP3117825A1
(en)
|
2015-07-16 |
2017-01-18 |
Rottapharm S.p.A. |
Oral formulation comprising berberine and morus alba extract
|
CN104984448B
(zh)
*
|
2015-07-30 |
2018-05-01 |
中山市美捷时包装制品有限公司 |
一种干粉吸入器
|
CN105013054B
(zh)
*
|
2015-07-30 |
2018-11-09 |
中山市美捷时包装制品有限公司 |
一种多胶囊型干粉吸入装置
|
UY36851A
(es)
|
2015-08-16 |
2017-03-31 |
Glaxosmithkline Ip Dev Ltd |
Compuestos para uso en aplicaciones antibacterianas
|
JP2018529745A
(ja)
|
2015-10-06 |
2018-10-11 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited |
Nrf2レギュレーターとしてのビアリールピラゾール
|
US10351530B2
(en)
|
2015-10-06 |
2019-07-16 |
Glaxosmithkline Intellectual Property Development Limited |
Arylcyclohexyl pyrazoles as NRF2 regulators
|
CA3004492A1
(en)
|
2015-11-18 |
2017-05-26 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Pharmaceutical compositions of ribavirin
|
US11833118B2
(en)
|
2016-01-20 |
2023-12-05 |
Flurry Powders, Llc |
Encapsulation of lipophilic ingredients in dispersible spray dried powders suitable for inhalation
|
AU2017210319A1
(en)
|
2016-01-20 |
2018-08-23 |
Flurry Powders, Llc |
Encapsulation of lipophilic ingredients in dispersible spray dried powders suitable for inhalation
|
USD861975S1
(en)
|
2016-02-08 |
2019-10-01 |
Juul Labs, Inc. |
Vaporizer device with cartridges
|
SG11201806801VA
(en)
|
2016-02-11 |
2018-09-27 |
Juul Labs Inc |
Securely attaching cartridges for vaporizer devices
|
EP3413960B1
(en)
|
2016-02-11 |
2021-03-31 |
Juul Labs, Inc. |
Fillable vaporizer cartridge and method of filling
|
US11224705B2
(en)
|
2016-02-24 |
2022-01-18 |
Boehringer Ingelheim International Gmbh |
Inhaler
|
US10912333B2
(en)
|
2016-02-25 |
2021-02-09 |
Juul Labs, Inc. |
Vaporization device control systems and methods
|
TW201825458A
(zh)
|
2016-09-20 |
2018-07-16 |
英商葛蘭素史克智慧財產(第二)有限公司 |
Trpv4拮抗劑
|
US11260049B2
(en)
|
2016-09-20 |
2022-03-01 |
Glaxosmithkline Intellectual Property (No. 2) Limited |
TRPV4 antagonists
|
EP3515889A1
(en)
|
2016-09-20 |
2019-07-31 |
GlaxoSmithKline Intellectual Property (No. 2) Limited |
Trpv4 antagonists
|
WO2018102412A1
(en)
|
2016-11-30 |
2018-06-07 |
Neonc Technologies, Inc. |
A perillyl alcohol-3 bromopyruvate conjugate and methods of treating cancer
|
KR20190088404A
(ko)
|
2016-12-06 |
2019-07-26 |
글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 |
3-(2,3-디히드로-1h-인덴-5-일)프로판산 유도체 및 nrf2 조절제로서의 그의 용도
|
US10426698B2
(en)
*
|
2016-12-08 |
2019-10-01 |
Breeden Brothers, LLC |
Pill container with cap
|
US20200031820A1
(en)
|
2016-12-12 |
2020-01-30 |
Glsxosmithkline Intellectual Property Development Limited |
3-carboxylic acid pyrroles as nrf2 regulators
|
WO2018109642A1
(en)
|
2016-12-12 |
2018-06-21 |
Glaxosmithkline Intellectual Property Development Limited |
N-aryl pyrazoles as nrf2 regulators
|
ES2848699T3
(es)
|
2016-12-14 |
2021-08-11 |
Glaxosmithkline Ip Dev Ltd |
Compuestos de 3-oxo-1,4-diazepinilo como activadores de NRF2
|
WO2018109643A1
(en)
|
2016-12-14 |
2018-06-21 |
Glaxosmithkline Intellectual Property Development Limited |
Bisaryl heterocycles as nrf2 acti
|
US11078216B2
(en)
|
2016-12-14 |
2021-08-03 |
Glaxosmithkline Intellectual Property Development Limited |
Bisaryl amides as NRF2 activators
|
CN110114361B
(zh)
|
2016-12-15 |
2022-04-12 |
葛兰素史密斯克莱知识产权发展有限公司 |
Nrf2化合物
|
US11059816B2
(en)
|
2016-12-15 |
2021-07-13 |
Glaxosmithkline Intellectual Property Development Limited |
Ether linked triazoles as NRF2 activators
|
EP3599899A1
(en)
|
2017-03-23 |
2020-02-05 |
Virun, Inc. |
Stable dry powders and emulsions containing probiotics and mucoadhesive protein
|
EA039181B1
(ru)
|
2017-04-24 |
2021-12-15 |
Кокристал Фарма, Инк. |
Производные пирролопиримидина, пригодные в качестве ингибиторов репликации вируса гриппа
|
US20210177861A1
(en)
|
2017-12-11 |
2021-06-17 |
Glaxosmithkline Intellectual Property Development Limited |
Nrf2 activator for the treatment of acute lung injury, acute respiratory distress syndrome and multiple organ dysfunction syndrome
|
WO2019116231A1
(en)
|
2017-12-11 |
2019-06-20 |
Glaxosmithkline Intellectual Property Development Limited |
Nrf2 activator for the treatment of acute lung injury, acute respiratory distress syndrome and multiple organ dysfunction syndrome
|
GB201720989D0
(en)
|
2017-12-15 |
2018-01-31 |
Glaxosmithkline Ip Dev Ltd |
Chemical compounds
|
UY38051A
(es)
|
2018-01-17 |
2019-08-30 |
Glaxosmithkline Ip Dev Ltd |
INHIBIDORES DE LA PI4KIIIß
|
DK3749291T3
(da)
|
2018-02-08 |
2024-04-08 |
Univ Southern California |
Fremgangsmåder til permeabilisering af blod-hjerne-barrieren
|
US11643407B2
(en)
|
2018-05-23 |
2023-05-09 |
Glaxosmithkline Intellectual Property Development Limited |
Indanes as NRF2 activators
|
EP3829719A1
(en)
|
2018-07-27 |
2021-06-09 |
Cocrystal Pharma, Inc. |
Pyrrolo[2,3-b]pyridin derivatives as inhibitors of influenza virus replication
|
ES2937837T3
(es)
|
2018-09-10 |
2023-03-31 |
Cocrystal Pharma Inc |
Inhibidores de piridopirazina y piridotriazina de la replicación del virus de la gripe
|
KR20210080413A
(ko)
|
2018-10-17 |
2021-06-30 |
코크리스탈 파마, 아이엔씨. |
인플루엔자 바이러스 복제 억제제의 조합물
|
CA3119145A1
(en)
|
2018-11-13 |
2020-05-22 |
Cocrystal Pharma, Inc. |
Formulations comprising 3-(2-(5-chloro-1h-pyrrolo[2,3-b]pyridin-3-yl)-5-fluoro-7h-pyrrolo[2,3-d]pyrimid-7-yl)bicyclo[2.2.2]octane-2-carboxylic acid for the treatment of influenza
|
WO2020112716A1
(en)
|
2018-11-26 |
2020-06-04 |
Cocrystal Pharma, Inc. |
Inhibitors of influenza virus replication
|
DE102020100550A1
(de)
*
|
2019-01-14 |
2020-07-16 |
Alfred Von Schuckmann |
Vorrichtung zum Inhalieren pulverförmiger Substanzen, Substanzbehälter für eine solche Vorrichtung sowie Verfahren zum Befüllen einer derartigen Vorrichtung
|
DE102019134285A1
(de)
|
2019-01-15 |
2020-07-16 |
Nuuvera Deutschland GmbH |
Vorrichtung und Verfahren zum Extrahieren und Aspirieren von Wirkstoffen, insbesondere aus der Cannabispflanze
|
CA3132082A1
(en)
|
2019-03-14 |
2020-09-17 |
Om Pharma Sa |
Method of treating and/or preventing asthma, asthma exacerbations, allergic asthma and/or associated conditions with microbiota related to respiratory disorders
|
EP3937957A1
(en)
|
2019-03-14 |
2022-01-19 |
OM Pharma SA |
Process for making stable bacterial extracts and their use as pharmaceuticals
|
GB201908536D0
(en)
|
2019-06-13 |
2019-07-31 |
Glaxosmithkline Ip Dev Ltd |
Compounds
|
USD943159S1
(en)
|
2019-11-14 |
2022-02-08 |
Juul Labs, Inc. |
Component for a vaporizer cartridge
|
USD943160S1
(en)
|
2019-11-14 |
2022-02-08 |
Juul Labs, Inc. |
Vaporizer device
|
USD943161S1
(en)
|
2019-11-14 |
2022-02-08 |
Juul Labs, Inc. |
Vaporizer device
|
USD943158S1
(en)
|
2019-11-14 |
2022-02-08 |
Juul Labs, Inc. |
Vaporizer cartridge
|
US20230151034A1
(en)
|
2020-03-17 |
2023-05-18 |
Cocrystal Pharma, Inc. |
Peptidomimetic n5-methyl-n2-(nonanoyl-l-leucyl)-l-glutaminate derivatives, triazaspiro[4.14]nonadecane derivatives and similar compounds as inhibitors of norovirus and coronavirus replication
|
EP4132944A1
(en)
|
2020-04-10 |
2023-02-15 |
Cocrystal Pharma, Inc. |
Inhibitors of norovirus and coronavirus replication
|
US20230158125A1
(en)
|
2020-04-20 |
2023-05-25 |
Sorrento Therapeutics, Inc. |
Pulmonary Administration of ACE2 Polypeptides
|
WO2022175425A1
(en)
|
2021-02-22 |
2022-08-25 |
Glaxosmithkline Intellectual Property Development Limited |
Inhaled mtor kinase inhibitors for use in the treatment or the prevention of a respiratory rna virus infection
|
WO2022179967A1
(en)
|
2021-02-23 |
2022-09-01 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Vadadustat for treating covid-19 in a hospitalized subject
|
WO2022240897A1
(en)
|
2021-05-10 |
2022-11-17 |
Sepelo Therapeutics, Llc |
Pharmaceutical composition comprising delafloxacin for administration into the lung
|
IL310394A
(en)
|
2021-08-03 |
2024-03-01 |
Cocrystal Pharma Inc |
Corona virus inhibitors
|
WO2023028364A1
(en)
|
2021-08-27 |
2023-03-02 |
Sepelo Therapeutics, Llc |
Targeted compositions and uses therof
|
WO2023205389A1
(en)
|
2022-04-22 |
2023-10-26 |
Quench Medical Inc. |
Dry powder inhalation delivery of pharmaceuticals
|
WO2023232976A1
(en)
|
2022-06-03 |
2023-12-07 |
Ags Therapeutics Sas |
Extracellular vesicles from genetically-modified microalgae containing endogenously-loaded cargo, their preparation, and uses
|